CEVEC Pharmaceuticals GmbH and BioLamina AB have formed a collaboration for the commercial production of research grade and clinical grade laminins for ex vivo cell culture applications using CEVEC’s proprietary CAP Go technology, which, according to the company, is optimal for the production of these otherwise difficult to produce recombinant glycoproteins. CEVEC will provide its expertise in process development as well as its competence in GMP production, in collaboration with its joi...